LPTH vs. AYTU
LPTH (LightPath Technologies, Inc.) and AYTU (Aytu BioPharma, Inc.) are both stocks. LPTH operates in Electronic Components (Technology), while AYTU operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, LPTH returned 38.88%/yr vs -54.38%/yr for AYTU. At a 0.12 correlation, their price movements are largely independent.
Performance
LPTH vs. AYTU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LPTH achieves a 32.04% return, which is significantly higher than AYTU's -17.31% return.
LPTH
- 1D
- -8.82%
- 1M
- 23.78%
- YTD
- 32.04%
- 6M
- 76.05%
- 1Y
- 360.00%
- 3Y*
- 116.77%
- 5Y*
- 38.88%
- 10Y*
- 22.79%
AYTU
- 1D
- -1.83%
- 1M
- -1.83%
- YTD
- -17.31%
- 6M
- -6.52%
- 1Y
- 10.26%
- 3Y*
- 6.50%
- 5Y*
- -54.38%
- 10Y*
- —
LPTH vs. AYTU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LPTH LightPath Technologies, Inc. | 32.04% | 205.95% | 180.16% | 3.28% | -50.00% | -37.76% | 440.69% | -51.34% | -32.88% | 28.32% |
AYTU Aytu BioPharma, Inc. | -17.31% | 52.94% | -40.14% | -24.87% | -86.00% | -77.42% | -38.35% | 22.41% | -98.22% | -89.38% |
Correlation
The correlation between LPTH and AYTU is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2017 | 0.12 |
The correlation between LPTH and AYTU shifts across timeframes, from 0.12 (3 years) to 0.24 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
LPTH:
$836.05M
AYTU:
$22.60M
LPTH:
-$85.64K
AYTU:
-$2.91
LPTH:
0.00
AYTU:
0.44
LPTH:
0.00
AYTU:
0.64
LPTH:
$19.15T
AYTU:
$56.60M
LPTH:
$6.96T
AYTU:
$36.14M
LPTH:
-$4.25T
AYTU:
-$27.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LPTH vs. AYTU — Risk / Return Rank
LPTH
AYTU
LPTH vs. AYTU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for LightPath Technologies, Inc. (LPTH) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LPTH | AYTU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.38 | ||
| Sortino ratioReturn per unit of downside risk | +2.68 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.08 | +0.32 |
| Calmar ratioReturn relative to maximum drawdown | 10.18 | 0.29 | +9.89 |
| Martin ratioReturn relative to average drawdown | 23.51 | 0.68 | +22.83 |
Loading charts...
Drawdowns
LPTH vs. AYTU - Drawdown Comparison
The maximum LPTH drawdown since its inception was -99.65%, roughly equal to the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for LPTH and AYTU.
Loading charts...
Drawdown Indicators
| LPTH | AYTU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.65% | -100.00% | +0.35% |
Max Drawdown (1Y)Largest decline over 1 year | -40.52% | -35.47% | -5.05% |
Max Drawdown (3Y)Largest decline over 3 years | -61.08% | -70.24% | +9.16% |
Max Drawdown (5Y)Largest decline over 5 years | -64.66% | -99.12% | +34.46% |
Max Drawdown (10Y)Largest decline over 10 years | -86.28% | — | — |
Current DrawdownCurrent decline from peak | -78.17% | -100.00% | +21.83% |
Average DrawdownAverage peak-to-trough decline | -86.30% | -95.26% | +8.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.52% | 15.16% | +2.36% |
Volatility
LPTH vs. AYTU - Volatility Comparison
LightPath Technologies, Inc. (LPTH) has a higher volatility of 37.05% compared to Aytu BioPharma, Inc. (AYTU) at 12.94%. This indicates that LPTH's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LPTH | AYTU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 37.05% | 12.94% | +24.11% |
Volatility (6M)Calculated over the trailing 6-month period | 83.89% | 33.57% | +50.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 115.53% | 54.47% | +61.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.02% | 85.63% | -2.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.57% | 188.01% | -108.44% |
Dividends
LPTH vs. AYTU - Dividend Comparison
Neither LPTH nor AYTU has paid dividends to shareholders.
Financials
LPTH vs. AYTU - Financials Comparison
This section allows you to compare key financial metrics between LightPath Technologies, Inc. and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LPTH vs. AYTU - Profitability Comparison
LPTH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LightPath Technologies, Inc. reported a gross profit of 6.96T and revenue of 19.15T. Therefore, the gross margin over that period was 36.3%.
AYTU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a gross profit of 7.60M and revenue of 12.41M. Therefore, the gross margin over that period was 61.2%.
LPTH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LightPath Technologies, Inc. reported an operating income of -4.25T and revenue of 19.15T, resulting in an operating margin of -22.2%.
AYTU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported an operating income of -4.06M and revenue of 12.41M, resulting in an operating margin of -32.8%.
LPTH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LightPath Technologies, Inc. reported a net income of -4.11T and revenue of 19.15T, resulting in a net margin of -21.4%.
AYTU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a net income of -5.62M and revenue of 12.41M, resulting in a net margin of -45.3%.
Frequently Asked Questions
LPTH and AYTU have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LPTH has higher volatility (37.05%) compared to AYTU (12.94%). In terms of maximum drawdown, LPTH dropped -99.65% vs AYTU's -100.00%.
LPTH currently has the higher Sharpe Ratio (3.57 vs 0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LPTH and AYTU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer